Antibodies are?proteins that protect you when an unwanted substance enters your body.
The global IL-17 Antibody market is projected to reach US$ 36 million in 2029, increasing from US$ 10 million in 2022, with the CAGR of 20.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole IL-17 Antibody market research.
A surge in research and development activities among pharmaceutical market leaders to develop economical andeffective antibodies and biosimilar antibodies is driving growth opportunities for the antibodies market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global IL-17 Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher Scientific
ProSci
FineTest
Sino Biological
Miltenyi Biotec
Merck
Santa Cruz Biotechnology
Proteintech
United States Biological
BioLegend
Bio-Rad
Bio X Cell
Hytest
Everest Biotech
Segment by Type
Polyclonal
Monoclonal
Segment by Application
Enzyme Linked Immunosorbent Assay
Immunohistochemistry Frozen
Immunohistochemistry Paraffin
Western Blot
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The IL-17 Antibody report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IL-17 Antibody Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Polyclonal
1.2.3 Monoclonal
1.3 Market by Application
1.3.1 Global IL-17 Antibody Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Enzyme Linked Immunosorbent Assay
1.3.3 Immunohistochemistry Frozen
1.3.4 Immunohistochemistry Paraffin
1.3.5 Western Blot
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global IL-17 Antibody Market Perspective (2018-2029)
2.2 IL-17 Antibody Growth Trends by Region
2.2.1 Global IL-17 Antibody Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 IL-17 Antibody Historic Market Size by Region (2018-2023)
2.2.3 IL-17 Antibody Forecasted Market Size by Region (2024-2029)
2.3 IL-17 Antibody Market Dynamics
2.3.1 IL-17 Antibody Industry Trends
2.3.2 IL-17 Antibody Market Drivers
2.3.3 IL-17 Antibody Market Challenges
2.3.4 IL-17 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IL-17 Antibody Players by Revenue
3.1.1 Global Top IL-17 Antibody Players by Revenue (2018-2023)
3.1.2 Global IL-17 Antibody Revenue Market Share by Players (2018-2023)
3.2 Global IL-17 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by IL-17 Antibody Revenue
3.4 Global IL-17 Antibody Market Concentration Ratio
3.4.1 Global IL-17 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IL-17 Antibody Revenue in 2022
3.5 IL-17 Antibody Key Players Head office and Area Served
3.6 Key Players IL-17 Antibody Product Solution and Service
3.7 Date of Enter into IL-17 Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 IL-17 Antibody Breakdown Data by Type
4.1 Global IL-17 Antibody Historic Market Size by Type (2018-2023)
4.2 Global IL-17 Antibody Forecasted Market Size by Type (2024-2029)
5 IL-17 Antibody Breakdown Data by Application
5.1 Global IL-17 Antibody Historic Market Size by Application (2018-2023)
5.2 Global IL-17 Antibody Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America IL-17 Antibody Market Size (2018-2029)
6.2 North America IL-17 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America IL-17 Antibody Market Size by Country (2018-2023)
6.4 North America IL-17 Antibody Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe IL-17 Antibody Market Size (2018-2029)
7.2 Europe IL-17 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe IL-17 Antibody Market Size by Country (2018-2023)
7.4 Europe IL-17 Antibody Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific IL-17 Antibody Market Size (2018-2029)
8.2 Asia-Pacific IL-17 Antibody Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific IL-17 Antibody Market Size by Region (2018-2023)
8.4 Asia-Pacific IL-17 Antibody Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America IL-17 Antibody Market Size (2018-2029)
9.2 Latin America IL-17 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America IL-17 Antibody Market Size by Country (2018-2023)
9.4 Latin America IL-17 Antibody Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IL-17 Antibody Market Size (2018-2029)
10.2 Middle East & Africa IL-17 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa IL-17 Antibody Market Size by Country (2018-2023)
10.4 Middle East & Africa IL-17 Antibody Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific IL-17 Antibody Introduction
11.1.4 Thermo Fisher Scientific Revenue in IL-17 Antibody Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 ProSci
11.2.1 ProSci Company Detail
11.2.2 ProSci Business Overview
11.2.3 ProSci IL-17 Antibody Introduction
11.2.4 ProSci Revenue in IL-17 Antibody Business (2018-2023)
11.2.5 ProSci Recent Development
11.3 FineTest
11.3.1 FineTest Company Detail
11.3.2 FineTest Business Overview
11.3.3 FineTest IL-17 Antibody Introduction
11.3.4 FineTest Revenue in IL-17 Antibody Business (2018-2023)
11.3.5 FineTest Recent Development
11.4 Sino Biological
11.4.1 Sino Biological Company Detail
11.4.2 Sino Biological Business Overview
11.4.3 Sino Biological IL-17 Antibody Introduction
11.4.4 Sino Biological Revenue in IL-17 Antibody Business (2018-2023)
11.4.5 Sino Biological Recent Development
11.5 Miltenyi Biotec
11.5.1 Miltenyi Biotec Company Detail
11.5.2 Miltenyi Biotec Business Overview
11.5.3 Miltenyi Biotec IL-17 Antibody Introduction
11.5.4 Miltenyi Biotec Revenue in IL-17 Antibody Business (2018-2023)
11.5.5 Miltenyi Biotec Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck IL-17 Antibody Introduction
11.6.4 Merck Revenue in IL-17 Antibody Business (2018-2023)
11.6.5 Merck Recent Development
11.7 Santa Cruz Biotechnology
11.7.1 Santa Cruz Biotechnology Company Detail
11.7.2 Santa Cruz Biotechnology Business Overview
11.7.3 Santa Cruz Biotechnology IL-17 Antibody Introduction
11.7.4 Santa Cruz Biotechnology Revenue in IL-17 Antibody Business (2018-2023)
11.7.5 Santa Cruz Biotechnology Recent Development
11.8 Proteintech
11.8.1 Proteintech Company Detail
11.8.2 Proteintech Business Overview
11.8.3 Proteintech IL-17 Antibody Introduction
11.8.4 Proteintech Revenue in IL-17 Antibody Business (2018-2023)
11.8.5 Proteintech Recent Development
11.9 United States Biological
11.9.1 United States Biological Company Detail
11.9.2 United States Biological Business Overview
11.9.3 United States Biological IL-17 Antibody Introduction
11.9.4 United States Biological Revenue in IL-17 Antibody Business (2018-2023)
11.9.5 United States Biological Recent Development
11.10 BioLegend
11.10.1 BioLegend Company Detail
11.10.2 BioLegend Business Overview
11.10.3 BioLegend IL-17 Antibody Introduction
11.10.4 BioLegend Revenue in IL-17 Antibody Business (2018-2023)
11.10.5 BioLegend Recent Development
11.11 Bio-Rad
11.11.1 Bio-Rad Company Detail
11.11.2 Bio-Rad Business Overview
11.11.3 Bio-Rad IL-17 Antibody Introduction
11.11.4 Bio-Rad Revenue in IL-17 Antibody Business (2018-2023)
11.11.5 Bio-Rad Recent Development
11.12 Bio X Cell
11.12.1 Bio X Cell Company Detail
11.12.2 Bio X Cell Business Overview
11.12.3 Bio X Cell IL-17 Antibody Introduction
11.12.4 Bio X Cell Revenue in IL-17 Antibody Business (2018-2023)
11.12.5 Bio X Cell Recent Development
11.13 Hytest
11.13.1 Hytest Company Detail
11.13.2 Hytest Business Overview
11.13.3 Hytest IL-17 Antibody Introduction
11.13.4 Hytest Revenue in IL-17 Antibody Business (2018-2023)
11.13.5 Hytest Recent Development
11.14 Everest Biotech
11.14.1 Everest Biotech Company Detail
11.14.2 Everest Biotech Business Overview
11.14.3 Everest Biotech IL-17 Antibody Introduction
11.14.4 Everest Biotech Revenue in IL-17 Antibody Business (2018-2023)
11.14.5 Everest Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Thermo Fisher Scientific
ProSci
FineTest
Sino Biological
Miltenyi Biotec
Merck
Santa Cruz Biotechnology
Proteintech
United States Biological
BioLegend
Bio-Rad
Bio X Cell
Hytest
Everest Biotech
*If Applicable.